Advertisement

Adrenal Cortical Hyperplasia

  • Lori A. Erickson
Chapter
Part of the Atlas of Anatomic Pathology book series (AAP)

Abstract

Adrenal cortical hyperplasia is characterized by an increase in cortical cells, which usually occurs bilaterally. Adrenal cortical hyperplasia generally affects both adrenal glands and may be diffuse or nodular or show features of both patterns. Adrenal glands may show hyperplasia primarily and secondarily. Primary adrenocorticotropic hormone (ACTH)-independent cortical hyperplasia is seen sporadically or in Carney complex. ACTH-dependent cortical hyperplasia occurs in congenital adrenal hyperplasia (adrenogenital syndrome), an autosomal recessive defect in an enzymatic step of steroid synthesis (most commonly 21-hydroxylase). The adrenal glands are enlarged as the result of continuous stimulation of the adrenal cortex by ACTH. Congenital adrenal hyperplasia is the most common cause of primary adrenal insufficiency in children. Secondary adrenal cortical hyperplasia is caused by pituitary ACTH adenoma, often a microadenoma, or ectopic ACTH production. The adrenal glands show a diffuse and/or micronodular pattern. These specimens, however, rarely are removed and evaluated by pathologists, because removal of the pituitary tumor is the mainstay of treatment. Other ectopic sites of ACTH production may occur and may be associated with hypercortisolism.

Keywords

Adrenal Gland Pituitary Adenoma Congenital Adrenal Hyperplasia Autosomal Recessive Defect Carney Complex 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Lack EE. Tumors of the adrenal glands and extraadrenal paraganglia. In: Silverberg SG, Sobin LH, editors. AFIP atlas of tumor pathology. 8th ed. Washington: American Registry of Pathology; 2007. p. 500.Google Scholar
  2. 2.
    Stratakis CA, Horvath A. Carney complex. In: Pagon RA, Adam MP, Bird TD, et al. editors. GeneReviews™ [Internet]. Seattle: University of Washington; 2003. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1286/.
  3. 3.
    Carney JA. Carney complex: the complex of myxomas, spotty pigmentation, endocrine overactivity, and schwannomas. Semin Dermatol. 1995;14(2):90–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Carney JA, Stratakis CA. Epithelioid blue nevus and psammomatous melanotic schwannoma: the unusual pigmented skin tumors of the Carney complex. Semin Diagn Pathol. 1998;15(3):216–24.PubMedGoogle Scholar
  5. 5.
    Boikos SA, Stratakis CA. Carney complex: pathology and molecular genetics. Neuroendocrinology. 2006;83(3–4):189–99.PubMedCrossRefGoogle Scholar
  6. 6.
    Kirschner LS, et al. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet. 2000;26(1):89–92.PubMedCrossRefGoogle Scholar
  7. 7.
    Stratakis CA. Adrenocortical tumors, primary pigmented adrenocortical disease (PPNAD)/Carney complex, and other bilateral hyperplasias: the NIH studies. Horm Metab Res. 2007;39(6):467–73.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Lori A. Erickson
    • 1
  1. 1.Mayo Clinic College of MedicineRochesterUSA

Personalised recommendations